San Diego cou­ple charged with steal­ing trade se­crets, open­ing Chi­nese biotech as DOJ crack­down con­tin­ues

3 hours ago
China
R&D

Scott Got­tlieb is once again join­ing a team that en­joyed good times at the FDA un­der his high-en­er­gy stint at the helm

3 hours ago
People

UP­DAT­ED: Bio­gen pulls the plug on prized IPF drug from $562M+ Stromedix buy­out

5 hours ago
R&D

Scott Got­tlieb has a new board po­si­tion to add to the re­sume — and this one is fo­cused on a fa­vorite sub­ject

Yesterday
People
Pharma

UP­DAT­ED: Deb­o­rah Dun­sire is pay­ing $2B for a chance to leap di­rect­ly in­to a block­buster show­down with a few of the world's biggest phar­ma gi­ants

Yesterday
Deals

It's not per­fect, but it's a good start: FDA pan­elists large­ly en­dorse Aim­mune's peanut al­ler­gy ther­a­py

3 days ago
R&D
Regulatory

It’s fi­nal­ly over: Bio­gen, Ei­sai scrap big Alzheimer’s PhI­I­Is af­ter a pre­dictable BACE cat­a­stro­phe rais­es safe­ty fears

4 days ago
R&D

Star founders, in­ves­ti­ga­tors hud­dle around new Boston ac­cel­er­a­tor spot­light­ing young en­tre­pre­neurs

4 days ago
Startups

Chalk up a big win for Bain as Spring­Works IPO tops out at $162M

4 days ago
IPOs

FDA slaps a hold on one of Am­gen’s ear­ly-stage can­cer drugs, rais­ing car­diac tox con­cerns for a top prospect in the pipeline

4 days ago
R&D

Penn team adapts CAR-T tech, reengi­neer­ing mouse cells to treat car­diac fi­bro­sis

5 days ago
R&D

The mR­NA uni­corn Mod­er­na has more ear­ly-stage hu­man da­ta it wants to show off — reach­ing new peaks in prov­ing the po­ten­tial

5 days ago
R&D

Mer­ck KGaA touts FDA 'break­through' sta­tus, block­buster po­ten­tial in bid to woo in­vestors

6 days ago
R&D

Af­ter plen­ty of due dili­gence, GSK buys one biotech pup in the ‘$500M’ Aval­on lit­ter for its pipeline

6 days ago
Deals

Sanofi takes a $260M hit to ex­tri­cate it­self from a dis­as­trous al­liance with Lex­i­con

6 days ago
R&D

The End­points 100: No­var­tis gets 'poor' grade on da­ta scan­dal, Ned Sharp­less is­n't a 'wow' and that Cana­da drug im­por­ta­tion plan is a non­starter

Last week
Editor's note

A new play­er jumps in­to the heat­ed race for a sick­le cell cure, with help from Google's GV

Last week
Cell/Gene Tx
R&D

Alex Zha­voronkov fol­lows land­mark AI pa­per with $37M round for In­sil­i­co fea­tur­ing top-notch Chi­na VCs

Last week
AI
Venture

Fresh off the heels of mega fi­nanc­ing round, Ger­many's BioN­Tech makes $100M US IPO play

Last week
IPOs

CDER chief Janet Wood­cock has a mes­sage for phar­ma: 'It’s not work­ing, and it won’t work in the fu­ture'

Last week
People
Pharma

Aca­dia de­clares ear­ly win on Nu­plazid de­men­tia study, stun­ning an­a­lysts and send­ing shares soar­ing

Last week
Pharma
R&D

Tony Coles sets sail on new neu­ro pur­suit at Cerev­el, steer­ing Pfiz­er spin­out as CEO

Last week
People

Eli Lil­ly hus­tles up an im­pres­sive set of piv­otal da­ta for their $8B Loxo drug — as ri­val nips at their heels

Last week
R&D

MIT’s star tech gu­ru Joi Ito re­signs biotech chair post in wake of Jef­frey Ep­stein scan­dal

Last week
People
1234 Next page Last page